NoviSystems Launches Data Analytics Solution for More Efficient Drug Manufacturing

02 November 2021 | Tuesday | News

NoviSystems Inc., a company that empowers data-driven decisionmaking, has commercially launched Fusion Analytics for Quality Systems, an analytics solution for improving operational performance at pharmaceutical and biopharmaceutical manufacturing facilities in the new era of individualized medicine.

With the emergence of cell/gene therapy and individualized treatments, Fusion Analytics for Quality Systems is even more essential as bio/pharma manufacturers deal with increasingly complex products, multiple lines and global in-house and outsourced sites," said Michael Kowolenko, Ph.D., founder and chief executive officer of NoviSystems and a former biomanufacturing executive. "Fusion Analytics for Quality Systems leverages a platform that can meet evolving needs in deviation, process and release analytics, leading to further improvements in operational performance."

The product launch comes after NoviSystem engineers developed and validated the solution in collaboration with Thermo Fisher Scientific Corp., a global scientific services company, at 16 of Thermo Fisher's drug-manufacturing sites around the world.

"With Fusion Analytics, our organization has taken a more systematic and data-driven approach to understanding our deviation trends," said Matt Wessel, Ph.D., data scientist in the Pharmaceutical Services Group at Thermo Fisher Scientific. "Fusion Analytics gives us the ability to quickly identify areas of weakness and implement appropriate and meaningful actions to help reduce and eliminate deviations across our global manufacturing network. Fusion Analytics has been a real benefit for our quality teams."

Fusion Analytics for Quality Systems is a targeted application of NoviSystems' Fusion Analytics platform, an integrated software and hardware solution based on IBM's Power9 and Open Shift architectures. The platform abstracts the complexity of natural language processing and machine learning techniques to help users generate actionable, "real world" answers from complex data sets without having to become data scientists.

Fusion Analytics is well suited for complex businesses in health care such as biopharmaceutical and pharmaceutical manufacturers, clinicians specializing in rare diseases, and contract research organizations. It can help them gain insights that save time and money, increasing profitability.

Thermo Fisher Scientific participated in NoviSystems' Proof of Value Program available to all new clients. 


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in